Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sancai Pharma, officially known as Zhejiang Sancai Pharmaceutical Co., Ltd., is a Chinese pharmaceutical company specializing in the manufacture and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is a significant producer of antibiotics and antiviral medications, with a portfolio that includes widely used drugs such as Cephalexin and Vidarabine Monophosphate. Based in Zhejiang province, Sancai Pharma operates large-scale manufacturing facilities that comply with international quality standards, serving both domestic and global markets. The company's business model focuses on high-volume production of essential generic medicines and chemical intermediates for the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sancai Pharma.